Onconaut Therapeutics

Onconaut Therapeutics is a South San Francisco-based biotechnology company dedicated to discovering and developing novel therapies for "undruggable" oncology targets. Founded by industry veterans with a track record of success in cancer drug development, the company leverages a proprietary platform to access high-value intracellular drivers of disease. Their primary focus is on creating small molecule inhibitors that can penetrate cells and modulate proteins previously considered beyond the reach of traditional medicine. Onconaut is currently in the pre-clinical stage, advancing a pipeline of programs aimed at treating various solid tumors. The company is supported by leading life science investors, including Venrock and GV.